News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

BioFocus DPI Creates Novel Diverse Screening Library



12/5/2011 10:11:20 AM

Saffron Walden, UK, 05 December 2011: BioFocus, an integrated drug discovery partner, today announced that it has enhanced its diverse screening library through new compound supply agreements with InterBioScreen, Enamine and ChemBridge. BioFocus now offers one of the most powerful screening platforms in the industry with over 900,000 unique chemical compounds and approximately 100,000 probes from natural sources.

Under the agreements BioFocus has selected a total of 350,000 new compounds. These compounds will replace a portion of the current screening library, resulting in a collection with significantly increased novelty, structural diversity and lead likeness, while increasing its overall solubility profile.

“Integrating our screening collection with our assay expertise has provided our clients with a platform that has the size and flexibility to deliver on their hit-finding campaigns”, said Kate Hilyard, Vice President Biological Sciences BioFocus. “This latest round of compound acquisition demonstrates our commitment to maintaining our reputation as a leading partner in drug discovery”.

Contacts

Product enquiries

Kate Hilyard

BioFocus

Tel: +44 (0)1799 533 500

Email: kate.hilyard@glpg.com

Media enquiries

Katie Odgaard

Zyme Communications

Tel: +44 (0)7787 502 947

Email: katie.odgaard@zymecommunications.com

About BioFocus

BioFocus provides integrated drug discovery that delivers pre-clinical drug candidates in all therapeutic areas with strong capability in neurodegenerative diseases, inflammatory diseases and with a growing track record of delivering candidates against rare and neglected diseases.

BioFocus has advanced and comprehensive drug discovery capabilities that are applied to client projects to deliver targets, hits, leads and candidate pre-clinical drugs. The company employs over 220 exceptionally qualified and industry experienced scientists at its three research centers in the UK, Switzerland and the Netherlands.

Since its foundation in 1997, BioFocus has striven to produce high quality data for its clients and this quality is assured by ISO9001 qualification validated by regular, independent inspection of all BioFocus research centers.

For more information visit www.biofocus.com


Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES